Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study

Journal of Hepatology

Volumn 58, Issue 4, 2013, Pages 715-723

  Angelico, Mario ^a,k   Nardi, Alessandra ^a   Marianelli, Tania ^a,k   Caccamo, Lucio ^b,k   Romagnoli, Renato ^c,k   Tisone, Giuseppe ^a   Pinna, Antonio D ^d   Avolio, Alfonso W ^e,k   Fagiuoli, Stefano ^f,k   Burra, Patrizia ^g,k   Strazzabosco, Mario ^h,i,k   Costa, Alessandro Nanni ^j  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Centro de Trapianti di Fegato   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f OSPEDALI RIUNITI   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

^h UNIVERSITY OF MILANO BICOCCA   (Italy)

ⁱ YALE UNIVERSITY   (United States)

^j Centro Nazionale Trapianti (CNT)   (Italy)

^k Italian Association for the Study of the Liver   (Italy)

more..

Author keywords

De novo HBV infection; Donor Risk Index; Donor recipient matching; HBcAb positive donors

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; NUCLEOSIDE ANALOG;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HAZARD RATIO; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ORGAN DONOR; OUTCOME ASSESSMENT; PORTAL VEIN THROMBOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY;

ADULT; AGED; COHORT STUDIES; DONOR SELECTION; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HUMANS; ITALY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TISSUE DONORS;

EID: 84880928400     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.11.025     Document Type: Article

References (28)

1. B. Alkofer, B. Samstein, J.V. Grarrera, C. Kin, D. Jan, and S. Belemare Extended-donor criteria liver allografts Semin Liver Dis 25 2006 221 233 (Pubitemid 44141929)
2. R.M. Merion, N.P. Goodrich, and S. Feng How can we define expanded criteria for liver donors? J Hepatol 45 2006 484 488 (Pubitemid 44307397)
3. S. Feng, N.P. Goodrich, and J.L. Bragg-Gresham Characteristics associated with liver graft failure: the concept of a donor risk index Am J Transplant 6 2006 783 790 (Pubitemid 43345017)
4. A.E. Braat, J.J. Blok, H. Putter, R. Adam, A.K. Burroughs, and A.O. Rahmel The eurotransplant donor risk index in liver transplantation: ET-DRI Am J Transplant 12 2012 2789 2796
5. G. Raimondo, J.P. Allain, M.R. Brunetto, M.A. Buendia, D.S. Chen, and M. Colombo Statements from the Taormina expert meeting on occult hepatitis B virus infection J Hepatol 49 2008 652 657
6. B. Cluster, S.D. Sullivan, and T.K. Hazlet Global epidemiology of hepatitis B virus J Clin Gastroenterol 38 2004 S158 S168
7. M. Angelico, U. Cillo, S. Fagiuoli, A. Gasbarrini, C. Gavrila, and T. Marianelli Liver match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching Digest Liver Dis 43 2011 155 164
8. O. Chazouillères, D. Mamish, M. Kim, K. Carey, L. Ferrell, and J.P. Roberts "Occult" hepatitis B virus as source of infection in liver transplant recipients Lancet 343 1994 142 146
9. R.C. Dickson, J.E. Everhart, J.R. Lake, Y. Wei, E.C. Seaberg, and R.H. Wiesner Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The national institute of diabetes and digestive and kidney diseases liver transplantation database Gastroenterology 113 1997 1668 1674 (Pubitemid 27461255)
10. M. Prieto, M.D. Gomez, M. Berenguer, J. Cordoba, J.M. Rayon, and M. Pastor De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population Liver transpl 7 2001 1 58
11. C. Manzarbeitia, D. Reich, J. Ortiz, K. Rosthstein, V. Araya, and S. Munoz Safe use of liver donors with positive hepatitis B core antibody Liver Transpl 8 2002 556 561 (Pubitemid 34619089)
12. A. Rokuhara, E. Tanaka, S. Yagi, M. Mizokami, Y. Hasshikura, and S. Kawasaki De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: analysis by determining complete sequence of the genome J Med Virol 62 2000 471 478
13. J. Burton, and T. Shaw-Stiffel Use of hepatitis B core antibody positive donors in recipients without evidence of hepatitis B infection: a survey of current practice in the United States Liver Transpl 9 2003 837 842 (Pubitemid 36974951)
14. R. Perrillo, and B. Hepatitis Virus prevention strategies for antibody to hepatitis B core antigen-positive liver donation: a survey of North American, European, and Asian Pacific transplant programs Liver Transpl 15 2009 223 232
15. E. Cholongitas, G.V. Papatheodoridis, and A.K. Burroughs Liver Grafts from anti-hepatitis B core positive donors: a systematic review J Hepatol 52 2010 272 279
16. S. Saab, B. Waterman, A.C. Chi, and M.J. Tong Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review Liver transpl 16 2010 300 307
17. V.I. Avelino-Silva, L.A. D'Albuquerque, P.R. Bonazzi, A.T. Song, J.L. Miraglia, and A. De Brito Neves Liver transplant from anti-HBc-positive, HBsAg-negative donor into HBsAg-negative recipient: is it safe? A systematic review of the literature Clin Transplant 24 2010 735 746
18. C.L. Skagen, J.H. Jou, and A. Said Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis Clin Transplant 25 2011 243 249
19. G. Vizzini, S. Gruttadauria, R. Volpes, A. D'Antoni, G. Pietrosi, and D. Fili Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts Clin Transplant 25 2011 E77 E81
20. L. Yu, T. Koepsell, L. Manhart, and G. Ioannou Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor Liver transpl 15 2009 1343 1350
21. D.R. Cox Regression models and life tables J Royal Stat Soc Series B 34 1972 187 220
22. T.M. Therneau, P.M. Grambsch, and T.R. Fleming Martingale-based residuals for survival models Biometrika 77 1990 147 160
23. D. Schoenfeld Partial residuals for the proportional hazards regression model Biometrika 69 1982 239 241
24. T.M. Therneau, and P.M. Grambsch Proportional hazards test and diagnostics based on weighted residuals Biometrika 81 1994 515 526
25. K.R. Hess Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions Stat Med 13 1994 1045 1062 (Pubitemid 24169931)
26. G.N. Brock, F. Mostajabi, N. Ferguson, C.J. Carrubba, M. Eng, and J.F. Buell Prophylaxis against de novo hepatitis B for liver transplantation utilizing Hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage? Transpl Int 24 2011 570 581
27. E. Sagnelli, G. Pasquale, N. Coppola, C. Marrocco, F. Scarano, and M. Imparato Liver histology in patients with HBsAg negative, anti-HBc and anti-HCV positive chronic hepatitis J Med Virol 75 2005 222 226 (Pubitemid 40053732)
28. C.K. Hui, E. Lau, H. Wu, A. Monto, M. Kim, and J.M. Luk Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection J Clin Virol 35 2006 185 192 (Pubitemid 43053395)